Literature DB >> 19749434

Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes.

AnnaMaria Cimini1, Sandra Moreno, Marcello D'Amelio, Loredana Cristiano, Barbara D'Angelo, Stefano Falone, Elisabetta Benedetti, Paolo Carrara, Francesca Fanelli, Francesco Cecconi, Fernanda Amicarelli, Maria Paola Cerù.   

Abstract

The central role of peroxisomes in reactive oxygen species and lipid metabolism and their importance in brain functioning are well established. The aim of this work has been to study the peroxisomal population in the Tg2576 mouse model of Alzheimer's disease (AD), at the age of three months when no apparent signs of behavioral, neuroanatomical, cytological, or biochemical alterations have been so far described. The expression and localization of peroxisomal (PMP70, CAT, AOX, and THL) and peroxisome-related proteins (PEX5p, GPX1, SOD1, and SOD2) were studied in the neocortex and hippocampus of transgenic and wild-type animals. Oxidative stress markers (TBARS, acrolein, and 8-OHG) were also evaluated. Our results demonstrate that significant alterations are already detectable at this early stage of the disease and also involve peroxisomes. Their number and protein composition change concomitantly with early oxidative stress. Interestingly, the neocortex shows a compensatory response, consisting in an increase of reactive oxygen species scavenging enzymes, while the hippocampus appears more prone to the oxidative insult. This different behavior could be related to metabolic differences in the two brain areas, also involving peroxisome abundance and/or enzymatic content.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749434     DOI: 10.3233/JAD-2009-1199

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  27 in total

Review 1.  The peroxisome: an update on mysteries.

Authors:  Markus Islinger; Sandra Grille; H Dariush Fahimi; Michael Schrader
Journal:  Histochem Cell Biol       Date:  2012-03-14       Impact factor: 4.304

Review 2.  Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2011-08-18

Review 3.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

4.  Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease.

Authors:  Virve Cavallucci; Nicola Berretta; Annalisa Nobili; Robert Nisticò; Nicola B Mercuri; Marcello D'Amelio
Journal:  Neuromolecular Med       Date:  2013-07-03       Impact factor: 3.843

5.  Dual effect of docosahexaenoic acid (attenuation or amplification) on C22:0-, C24:0-, and C26:0-induced mitochondrial dysfunctions and oxidative stress on human neuronal SK-N-BE cells.

Authors:  A Zarrouk; T Nury; J M Riedinger; O Rouaud; M Hammami; G Lizard
Journal:  J Nutr Health Aging       Date:  2015-02       Impact factor: 4.075

6.  Benzothiazole aniline tetra(ethylene glycol) and 3-amino-1,2,4-triazole inhibit neuroprotection against amyloid peptides by catalase overexpression in vitro.

Authors:  Amrutha Chilumuri; Mark Odell; Nathaniel G N Milton
Journal:  ACS Chem Neurosci       Date:  2013-09-09       Impact factor: 4.418

7.  Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer's disease model by modulating BDNF signaling pathway.

Authors:  Annamaria Cimini; Roberta Gentile; Barbara D'Angelo; Elisabetta Benedetti; Loredana Cristiano; Maria Laura Avantaggiati; Antonio Giordano; Claudio Ferri; Giovambattista Desideri
Journal:  J Cell Biochem       Date:  2013-10       Impact factor: 4.429

8.  Involvement of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) in BDNF signaling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE).

Authors:  Elisabetta Benedetti; Barbara D'Angelo; Loredana Cristiano; Erica Di Giacomo; Francesca Fanelli; Sandra Moreno; Francesco Cecconi; Alessia Fidoamore; Andrea Antonosante; Roberta Falcone; Rodolfo Ippoliti; Antonio Giordano; Annamaria Cimini
Journal:  Cell Cycle       Date:  2014-03-04       Impact factor: 4.534

Review 9.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

10.  Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment.

Authors:  Pol Andrés-Benito; Ellen Gelpi; Mariona Jové; Natalia Mota-Martorell; Èlia Obis; Manuel Portero-Otin; Mònica Povedano; Aurora Pujol; Reinald Pamplona; Isidro Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2021-01-12       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.